Revisiting G3BP1 as a RasGAP Binding Protein: Sensitization of Tumor Cells to Chemotherapy by the RasGAP 317–326 Sequence Does Not Involve G3BP1

Autor: Jamal Tazi, Sophie G. Martin, Christian Widmann, Aline Dousse, Alessandro Annibaldi
Přispěvatelé: Laboratoire de Spectrométrie Ionique et Moléculaire (LASIM), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Institut de pharmacologie moléculaire et cellulaire (IPMC), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)
Rok vydání: 2011
Předmět:
Proteomics
Untranslated region
Cancer Treatment
Apoptosis
Plasma protein binding
Biochemistry
Mice
0302 clinical medicine
Cricetinae
Molecular Cell Biology
Signaling in Cellular Processes
Poly-ADP-Ribose Binding Proteins
Peptide sequence
Apoptotic Signaling Cascade
Apoptotic Signaling
0303 health sciences
Multidisciplinary
Cell Death
Signaling Cascades
Cell biology
RNA Recognition Motif Proteins
Oncology
ras GTPase-Activating Proteins
030220 oncology & carcinogenesis
Medicine
RNA Helicases
Protein Binding
Research Article
Signal Transduction
Immunoprecipitation
Science
Ras Signaling
Biology
03 medical and health sciences
Stress granule
Tumor Cricetinae Drug Resistance
Cell Line
Tumor

Animals
Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Amino Acid Sequence
Protein Interactions
030304 developmental biology
Messenger RNA
Binding protein
DNA Helicases
Neoplasm/drug effects Humans Mice Mutagens/pharmacology Peptide Fragments/chemistry/*pharmacology Protein Binding ras GTPase-Activating Proteins/*chemistry/*metabolism
Proteins
Chemotherapy and Drug Treatment
Amino Acid Sequence Animals Apoptosis/drug effects Carrier Proteins/*metabolism Cell Line
Molecular biology
Peptide Fragments
Drug Resistance
Neoplasm

Carrier Proteins
Mutagens
Zdroj: PLoS ONE, Vol 6, Iss 12, p e29024 (2011)
PLoS One, vol. 6, no. 12, pp. e29024
PloS one
PLoS ONE
PLoS ONE, Public Library of Science, 2011, 6 (12), pp.e29024. ⟨10.1371/journal.pone.0029024⟩
ISSN: 1932-6203
Popis: International audience; RasGAP is a multifunctional protein that controls Ras activity and that is found in chromosomal passenger complexes. It also negatively or positively regulates apoptosis depending on the extent of its cleavage by caspase-3. RasGAP has been reported to bind to G3BP1 (RasGAP SH3-domain-binding protein 1), a protein regulating mRNA stability and stress granule formation. The region of RasGAP (amino acids 317-326) thought to bind to G3BP1 corresponds exactly to the sequence within fragment N2, a caspase-3-generated fragment of RasGAP, that mediates sensitization of tumor cells to genotoxins. While assessing the contribution of G3BP1 in the anti-cancer function of a cell-permeable peptide containing the 317-326 sequence of RasGAP (TAT-RasGAP(3)(1)(7)(-)(3)(2)(6)), we found that, in conditions where G3BP1 and RasGAP bind to known partners, no interaction between G3BP1 and RasGAP could be detected. TAT-RasGAP(3)(1)(7)(-)(3)(2)(6) did not modulate binding of G3BP1 to USP10, stress granule formation or c-myc mRNA levels. Finally, TAT-RasGAP(3)(1)(7)(-)(3)(2)(6) was able to sensitize G3BP1 knock-out cells to cisplatin-induced apoptosis. Collectively these results indicate that G3BP1 and its putative RasGAP binding region have no functional influence on each other. Importantly, our data provide arguments against G3BP1 being a genuine RasGAP-binding partner. Hence, G3BP1-mediated signaling may not involve RasGAP.
Databáze: OpenAIRE